… perfusion which may result in growth retardation, intra-uterine deaths, abortion, immature and premature deliveries.
Breast-feeding
There is significant accumulation of Atenolol in breast milk.
Neonates born to mothers who are receiving Atenolol at parturition or breast-feeding may be at risk of hypoglycaemia and bradycardia.
Fertility
There are no data available.
Identical in both labels. Surrounding text shown from Aurobindo Pharma - Milpharm Ltd..
… erfusion which may result in growth retardation, intra-uterine deaths, abortion, immature and premature deliveries.
Breast-feeding
There is significant accumulation of Tenormin in breast milk.
Neonates born to mothers who are receiving Tenormin at parturition or breast-feeding may be at risk of hypoglycaemia and bradycardia.
Identical in both labels. Surrounding text shown from Atnahs Pharma UK Ltd.
… perfusion which may result in growth retardation, intra-uterine deaths, abortion, immature and premature deliveries.
Breast-feeding:
There is significant accumulation of atenolol in breast milk.
Neonates born to mothers who are receiving atenolol at parturition or breast- feeding may be at risk of hypoglycaemia and bradycardia.
… with a decrease in placental perfusion which may result in intra-uterine deaths, immature and premature deliveries.
Breast-feeding
There is significant accumulation of Atenolol in breast milk.
Neonates born to mothers who are receiving Atenolol at parturition or breast-feeding may be at risk of hypoglycaemia and bradycardia
… uded
Administration of atenolol in pregnancy has been associated with reduced foetal growth. Atenolol has been used under close supervision for the treatment of hypertension in the third trimester.
On the basis of its pharmacological properties, adverse effects may occur in the foetus and newborn infant, if used in the first and second trimesters (especially hypoglycaemia, hypotension and bradycardia). Beta-blockers reduce placental perfusion which may result in intra-uterine deaths, immature and premature deliveries.
Breast-feeding
Atenolol is excreted into breast milk reaching higher concentration than in plasma. A risk in the breastfed child cannot be excluded (beta-blockade). Neonates born to mothers wh …
… rease in placental perfusion which may result in growth retardation, intra-uterine deaths, abortion, immature and premature deliveries.
There is significant accumulation of atenolol in breast milk.
Neonates born to mothers who are receiving atenolol at parturition or breast-feeding may be at risk of hypoglycaemia and bradycardia.
Caution should be exercised when atenolol is administered during pregnancy or to a woman who is breast-feeding.